The presence of clonal T cells targeting shared antigens across the heart, skeletal muscle, and tumor tissue, along with elevated inflammatory mediators such as IFN-γ and TNF-α, further supports the immune-driven pathogenesis of myocarditis related to ICI therapy [19,22,23,24,28,29,30,33,38,39]. The gene discussed is TNF; the disease is myocarditis.